US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 2.160
  • -0.020-0.92%
Close Jul 22 16:00 ET
135.11MMarket Cap-4235P/E (TTM)

Corvus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corvus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 6, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.12

+29.41%
Analyst Rating

Buy

Jun 30, 2024

Corvus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 6, 20242024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 7, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 6, 20242024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 7, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Corvus Pharmaceuticals Earnings Reports

  • Corvus Pharmaceuticals | 10-Q: Quarterly report

    May 7 17:22 ET

  • Corvus Pharmaceuticals | 10-K: Annual report

    Mar 19 16:09 ET

  • Corvus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 16:02 ET

  • Corvus Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg